Scientists uncover novel role for estrogen in bone marrow

Scientists have discovered a new role for estrogen in maintaining health. Drs. Yuka Nagata and Kazuo Todokoro report in the December 1 issue of Genes & Development that the most abundant form of naturally occurring estrogen, estradiol, triggers the formation of blood platelet cells. This discovery has important clinical implications for the treatment of conditions associated with altered platelet counts, like anemia, certain leukemias, and even chemotherapy.

Blood is composed of 3 cell types: red blood cells, white blood cells, and platelets. Platelets circulate in the bloodstream to facilitate clotting and halt bleeding. Platelets are derived from a specialized bone marrow cell called a megakaryocyte. A mature megakaryocyte extends long cytoplasmic processes (termed proplatelets) from its cell surface that, in one of the most dramatic morphological changes known to cell biologists, simultaneously fragments into thousands of new platelet cells.

Dr. Nagata and colleagues set out to identify the cellular signal of this remarkable event. Previous work identified a gene regulator (what scientists refer to as a transcription factor) named p45 NF-E2 as being expressed in megakaryocyte cells and required for proplatelet formation. However, the target(s) of p45 NF-E2 were, until now, unknown.

Dr. Nagata found that the 3b-HSD gene is normally turned-on by p45 NF-E2 during megakaryocyte development. 3b-HSD encodes an enzyme that regulates all steroid hormone biosynthesis. Thus, Dr. Todokoro and colleagues explored which steroid hormones are produced in megakaryocyte cells. Much to their surprise, they found estrogen.

Dr. Nagata and colleagues determined that 3b-HSD induces the production of estrogen, in the form of estradiol, in both male and female megakaryocyte cells. Further work demonstrated a crucial role for estradiol in proplatelet formation, as evidenced by their finding that the addition of exogenous estradiol increased proplatelt formation by more than %50, while the inhibition of estradiol receptors blocked proplatelet formation in live mice.

Taken together, this work by Dr. Nagata and colleagues delineates a genetic mechanism for regulating the formation of blood platelets: The p45 NF-E2 transcription factor turns on 3b-HSD gene expression, leading to the synthesis of estradiol and the subsequent activation of proplatelet formation. Such insight will enable researchers and clinicians to devise therapeutic strategies to manipulate this process, either to increase or decrease proplatelet formation.

The authors suggest that patients suffering from low platelet counts, such as those with anemia, bone marrow abnormalities, or undergoing chemotherapy, may benefit from the administration of estradiol and/or a 3b-HSD activator, as an alternative to blood transfusions to increase platelet levels. Conversely, patients with abnormally high platelet counts, who are prone to forming clots and therefore at an increased risk for strokes, heart attacks, or even miscarriage (ie. from placental clots) would be candidates for drugs designed to specifically block 3b-HSD or estradiol receptors to effectively normalize their platelet levels.

Media Contact

Heather Cosel EurekAlert!

Further information:

http://www.cshl.org/

All news from this category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to the Homepage

Comments (0)

Write comment

Latest posts

Just a few atoms thick: New functional materials developed

Using the smallest “construction set” in the world, a research team from the universities of Marburg, Giessen and Paderborn is designing new materials for computer chips, light-emitting diodes and solar…

Researchers develop new metal-free, recyclable polypeptide battery

– that degrades on demand … This could result in battery production moving away from strategic elements like cobalt. The introduction of lithium-ion (Li-ion) batteries has revolutionized technology as a…

Artificial lungs as organ replacement

DFG priority program funds four MHH projects with 1.6 million euros. For people with severe lung diseases, transplantation of a healthy organ is often the only chance of survival. But…

Partners & Sponsors